Finding such discrepancies is critical to the continuity of patient care, as medical records and reports are often utilized across multiple providers and facilities. 

TAVR was initially associated with greater benefits than surgery, but that difference faded by the end of the first year.

The FDA initially made the complaint in January. Exactech has agreed to recall products at risk of chemical oxidation as a result of faulty packaging.

Cerebral has admitted to improperly sharing data with social media platforms for the purpose of targeted advertising. The company also made it difficult to cancel the service, costing its members millions.

Svensson, a prominent voice in cardiothoracic surgery, said he has seen a rise in enthusiasm ahead of this year's meeting.

Buzzworthy developments of the past few days.

Healthcare leaders around the U.S. might want to take notice of what’s going on in the streets of San Francisco this week.

Advanced imaging equipment using ionizing radiation enters the global market at the rate of one new technology every five years.